CDNA
Get informed when a big investor buys or sells
+ FollowOvervalued by 103.1% based on the discounted cash flow analysis.
| Market cap | $2.78 Billion |
|---|---|
| Enterprise Value | $2.42 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.4 |
| Beta | 2.43 |
| Outstanding Shares | 51,469,375 |
| P/E Ratio | 25.02 |
|---|---|
| PEG | -1.8 |
| Price to Sales | 6.79 |
| Price to Book Ratio | 6.79 |
| Enterprise Value to Revenue | 5.29 |
| Enterprise Value to EBIT | 21.84 |
| Enterprise Value to Net Income | 21 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 55,200▲ 171.92% |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 103.75%▲ 1.02% |
|---|---|
| Total Invested | $1.52B▲ 66.57% |
| Investors Holding | 233▲ 42.00% |
No data